Interim / Quarterly Report • Sep 23, 2022
Interim / Quarterly Report
Open in ViewerOpens in native device viewer

INTERIM FINANCIAL REPORT
FOR THE PERIOD FROM 1 JANUARY 2022 TO 30 JUNE 2022

| Page | ||
|---|---|---|
| - | Interim Board Report | 3 |
| - | Unaudited condensed interim financial statements Condensed interim statement of comprehensive income from 1 January 2022 to 30 June 2022 |
12 |
| Condensed interim statement of financial position as at 30 June 2022 | 13 | |
| Condensed interim statement of changes in equity from 1 January 2022 to 30 June 2022 |
14 | |
| Condensed interim statement of cash flows from 1 January 2022 to 30 June 2022 |
15 | |
| Notes to the condensed interim financial statements | 16 |

This interim financial report of Energy Transition Partners B.V. (hereinafter referred to as "Energy Transition" or the "Company") for the period from 1 January 2022 to 30 June 2022 consists of the report of the board of directors of the Company (the "Board", and such report the "Interim Board Report"), including the responsibility statement and other mandatory statements by the Board and the condensed interim financial statements and the accompanying notes (the "Half-Year Report").
This Half-Year Report also includes the financial results for the period from incorporation of the Company on 25 February 2021 to 30 June 2021 as comparative figures ("the 2021 Interim Period"). The 2021 Interim Period constitutes the half-year 2021 financial statements of the Company and is filed accordingly.
The Company was incorporated on 25 February 2021 under the name of EnTra Acquisition B.V. On 10 March 2021 the name of the Company was changed to Energy Transition Partners B.V. The Company has its registered office at Luna ArenA, Herikerbergweg 238, 1101 CM Amsterdam, the Netherlands.
The Company is a Special Purpose Acquisition Company (SPAC) with the purpose of effecting a merger, demerger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination with, or acquisition of, a business or company (a "Target") (a "Business Combination") operating in the Energy Transition Sector that is headquartered or operating in Europe (including UK), although it may pursue a business combination opportunity in any geography, industry or sector. Energy Transition Sponsor LLP (the "Sponsor") is the Sponsor of the Company.
The Company was admitted to listing and trading on Euronext Amsterdam (the "Admission"), the regulated market operated by Euronext Amsterdam N.V. ("Euronext Amsterdam") on 19 July 2021 pursuant to a private placement (the "Private Placement" or "Offering") in which it raised EUR 175 million in gross proceeds (the "Proceeds") in accordance with the terms and conditions set out in the Company's prospectus which has been issued on 15 July 2021 (the "Prospectus"). The Company completed the Offering of 17,500,000 units (the "Units"), each consisting of one ordinary share (an "Ordinary Share") and one-third (1/3) of a warrant (a "Warrant" or "Public Warrant"), at a price of EUR 10.00 per Unit raising gross proceeds of EUR 175 million. Payment for the Ordinary Shares and the Public Warrants ("Settlement") took place on 21 July 2021 (the "Settlement Date").
Since the Settlement Date, the Company has been focusing on the selection of a potential target company for the initial Business Combination. The process is currently ongoing, and the Company has 24 months from the Settlement Date, plus an additional six months subject to approval by the General Meeting, to complete a Business Combination.
The Company's business strategy is to identify, combine with and maximise the value of a Target with operations in the Energy Transition Sector. In executing this strategy, the Company will look for a Target that (i) complements the experience of the Founders, (ii) can benefit from the Founders' operating and financial expertise and (iii) represents a compelling investment opportunity for the Company and its investors.
If the Company identifies a suitable Target, the Company will enter into negotiations with the Target's current owners including, if appropriate, for the purpose of agreeing transaction documentation appropriate for the potential Business Combination.
The Company will publicly disclose material updates with respect to the transaction process leading up to the Business Combination, including the envisaged Business Combination Date. On the Business Combination Date, all documents will be signed and all such actions will be taken to legally complete the Business Combination. The Company will issue a press release to confirm that the Business Combination has been completed.

At the end of the June 2022, the Company has not proposed a specific target company to the Business Combination EGM. The Company will continue its search for a proposed Business Combination with a target company to be completed before the Business Combination Deadline.
According to the Articles, the issued capital of the Company may consist of Ordinary Shares (including the Founder Shares), the Founder Share F1 and the Company may issue Warrants and Founder Warrants.
The Company was incorporated with an issued share capital of EUR 62,500, consisting of 6,250,000 class A shares having a nominal value of EUR 0.01 each. These shares were converted into class B shares having a nominal value of EUR 0.01 each. An additional 3,750,000 class B shares were issued. The nominal value of each class B share in the capital of the Company was decreased from EUR 0.01 to EUR 0.0025. Each of these class B shares was converted into an ordinary share in the capital of the Company, and the nominal value of each such share was increased to EUR 0.01. Subsequently, various cancellations of in total 3,750,000 ordinary shares in the capital of the Company took place. As a result, on the date of the Prospectus, the issued share capital of the Company was EUR 43,750, consisting of 4,375,000 Founder Shares with a nominal value of EUR 0.01 each. As at 30 June 2022, following the repurchase of the shares from Mr Foster, 4,355,000 Founder Shares were issued and fully paid up.
Set out below is an overview of the Company's share capital for the dates stated in the overview:
| Class of Shares | Upon incorporati on |
At the date of the Prospectus |
On the Settlement Date: Issued share capital |
On the Settlement Date: Issued and outstanding share capital (1) |
On 30 June 2022: Issued and outstanding share capital (1) |
|---|---|---|---|---|---|
| Class A shares | 6,250,000 | - | - | - | - |
| Ordinary Shares | - | 4,375,000 | 91,875,000 | 21,875,000 | 21,855,000 |
| Of which Founder |
- | 4,375,000 | 4,375,000 | 4,375,000 | 4,355,000 |
| Shares | |||||
| Founder Share F1(2) | - | - | 1 | 1 | 1 |
(1) Issued and outstanding share capital is excluding any Shares held in treasury. See below "Treasury Shares and Treasury Warrants". (2) There is a single Founder Share F1, which the Sponsor acquired in the Founder Private Placement. See below "Founder Share F1".
The Ordinary Shares (for the avoidance of doubt, not including the Founder Shares) are issued in registered form and have been entered into the collective deposit (verzameldepot) and giro deposit (girodepot) as referred to in the Dutch Securities Giro Transactions Act (Wet giraal effectenverkeer). The Ordinary Shares are cleared through the book-entry facilities of Euroclear Nederland. The Ordinary Shares are listed and admitted to trading on Euronext Amsterdam under the symbol "ENTPA" and the ISIN NL0015000F82.
The Company maintains a separate share premium reserve in its books for the Ordinary Shares (excluding the Founder Shares) to which the holders of the Founder Shares are not entitled (the "Ordinary Share Premium Reserve"), which is for the exclusive benefit of the Ordinary Shareholders. Each payment on Ordinary Shares exceeding the nominal value of such Ordinary Shares shall be booked on the Ordinary Shares Premium Reserve. The Ordinary Shares will rank pari passu with each other and Ordinary Shareholders will be entitled to dividends and other distributions declared and paid on them, including distributions from the Ordinary Shares Premium Reserve.
Each Ordinary Share entitles its holder to the right to attend and to cast one vote at the General Meeting.

Time of issuance, exercise and expiration
Warrants are listed and admitted to trading on Euronext Amsterdam under the symbol "ENTPW" and the ISIN NL0015000FD2.
Each whole Warrant entitles an eligible Warrant Holder to subscribe for one Ordinary Share for EUR 11.50 per Warrant, subject to certain adjustments, in accordance with the Warrant T&Cs. All Warrants will become exercisable in the period which begins 30 calendar days after the Business Combination Date and ends at the earliest occurrence of:
The Warrants are issued in registered form and have been entered into the collective deposit (verzameldepot) and giro deposit (girodepot) as referred to in the Dutch Securities Giro Transactions Act. Application has been made for the Warrants to be cleared through the book-entry facilities of Euroclear Nederland. The Warrants do not have a fixed price or value. The price of the Warrants will be determined by virtue of trading on Euronext Amsterdam.
Warrant Holders may exercise their Warrants through the relevant participant of Euroclear Nederland through which they hold their Warrants, following applicable procedures for exercise and payment, including compliance with the applicable selling and transfer restrictions. No Warrants will be exercisable unless the issuance and delivery of the Ordinary Shares upon such exercise is permitted in the jurisdiction of the exercising Warrant Holder and the Company will not be obligated to issue any Ordinary Shares to Warrant Holders seeking to exercise their Warrants unless such exercise and delivery of Ordinary Shares is permitted in the jurisdiction of the exercising Warrant Holder. If such conditions are not satisfied with respect to a Warrant, the Warrant Holder will not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless.
The Founder Shares are ordinary shares in the capital of the Company, having a nominal value of EUR 0.01 each and numbered 1 through 4,375,000 (the "Founder Shares"), representing, in the aggregate, on a fully diluted basis, 20% of the total number of issued and outstanding Ordinary Shares on the Settlement Date.
The Founder Shares are listed and admitted to trading on Euronext Amsterdam under the symbol "ENTPA" (same as for the Ordinary Shares) and the ISIN NL0015000F82 (same as for the Ordinary Shares). Each of the Sponsor and the independent, non-executive Directors and Cornerstone Investors have waived their respective rights to dividends and other distributions declared and paid on them until completion of a Business Combination. Any dividends and other distributions declared and paid prior to that time will therefore not accrue in favour of the Founder Shares. The holders of Founder Shares are not entitled to distributions from the Ordinary Shares Premium Reserve. The Founder Shares will rank pari passu with each other and the Ordinary Shares.
All 4,375,000 Founder Shares will be registered in the name of the Sponsor, the non-executive Directors and the Cornerstone Investors in the Shareholders' Register and will be held outside the collective deposit and giro deposit as referred to in the Dutch Securities Transactions Act (Wet giraal effectenverkeer) until completion of a Business Combination. Subject to the satisfaction of the conditions set out below (the "Promote Schedule"), and subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalisations and the like:

Euroclear Nederland for the benefit of their holders and the economic rights with respect to these Founder Shares are no longer waived under the Letter Agreement (subject to the lock-up arrangements); and
The founder share F1 in the Company is denominated in euro with a nominal value of EUR 200,000 (the "Founder Share F1"). The Founder Share F1 is registered in the name of the Sponsor in the Shareholders' Register and held outside the collective deposit and giro deposit as referred to in the Dutch Securities Transactions Act (Wet giraal effectenverkeer). The Founder Share F1 is not listed or admitted to trading on Euronext Amsterdam or any other trading platform and will not be admitted to the clearing system operated by Euroclear Nederland. The Founder Share F1 does not carry any rights to distributions. The Founder Share F1 will be exchanged for an Ordinary Share at the Business Combination Date and held by the Company in treasury, unless the General Meeting resolves to cancel the Founder Share F1.
The Founder Share F1 entitles its holder to cast four votes in any General Meeting for each issued and outstanding Founder Share at the record date of that General Meeting. However, in the Letter Agreement, the Sponsor has agreed not to cast any vote on the Founder Share F1 in any General Meeting in respect of any resolution, including a resolution to complete a Business Combination. The Founder Share F1 allows its holder to attend a General Meeting and satisfy a quorum requirement which may be needed to adopt a resolution to complete a Business Combination through a legal merger, whether domestic or cross-border. Were such quorum not represented at the relevant General Meeting, the adoption of such resolution would require a majority of at least two-thirds of the votes cast by virtue of Dutch law.
Prior to or in connection with the completion of the Business Combination, only the Sponsor in its capacity as the holder of Founder Share F1 will have the right to vote in respect of:
The founder warrants (the "Founder Warrants") acquired by the Sponsor will not be admitted to listing and trading on any trading platform. The Founder Warrants will have substantially the same terms as the Warrants, including that each Founder Warrant entitles an eligible holder to subscribe for one Ordinary Share at EUR 11.50 per Founder Warrant, except that, so long as the Founder Warrants are held by the Sponsor or any of its Permitted Transferees:

(iii) the Founder Warrants may not be transferred, assigned or sold without the prior written consent of the Sole Global Coordinator, until 30 calendar days after the Business Combination, save for any transfer of the Founder Warrants made to any Permitted Transferees.
For the avoidance of doubt, Ordinary Shares received upon exercise of the Founder Warrants are not subject to any lock-up arrangements. If the Company does not complete a Business Combination by the Business Combination Deadline, the Founder Warrants will become void and all rights thereunder and all rights in respect thereof under the Warrant T&Cs shall cease as from that moment.
The Warrant T&Cs provide that, during the Exercise Period, the Sponsor or Permitted Transferees may elect to convert all or part of the Founder Warrants held by them into or exchange them for listed Warrants on a one-for-one basis by delivering to the Warrant Agent a notice of Founder Warrant conversion or exchange (in the form as requested by the Warrant Agent), and such request will be granted provided such conversion or exchange will not require the Company to publish a prospectus pursuant to the Prospectus Regulation.
If the Founder Warrants are exercised on a cashless basis, the Sponsor or its Permitted Transferees would exercise their Founder Warrants for that number of Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Founder Warrants, multiplied by the excess of the Sponsor Fair Market Value (as defined below) over the Exercise Price of the Founder Warrants plus any withholding by the Company with respect to the relevant holder of the Founder Warrants by (y) the volume-weighted average price of the Ordinary Shares for the ten Trading Days ending on the third Trading Day prior to the date on which the notice of Founder Warrant exercise is sent to the Warrant Agent (the "Sponsor Fair Market Value").
So long as the Sponsor remains affiliated with the Company, its ability to sell Ordinary Shares in the open market will be significantly limited. The Company has policies in place that restrict insiders from selling the Company's securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell the Company's securities, an insider cannot trade in the Company's securities if he or she is in possession of inside information. Accordingly, unlike Ordinary Shareholders who could exercise their Warrants and sell the Ordinary Shares received upon such exercise freely in the open market in order to recoup the cost of such exercise, the Sponsor or Permitted Transferees could be significantly restricted from selling such securities. As a result, the Company believes that allowing the holders of Founder Warrants to exercise such Founder Warrants on a cashless basis is appropriate.
The Company issued to, and immediately repurchased from, the Sponsor (i) 70,000,000 Ordinary Shares and (ii) 23,333,332 Warrants, all at the same value (so that no net proceeds remained with or is due by the Company), for the purpose of holding these in treasury for purposes of, inter alia,
The Company maintains a one-tier board structure consisting of Executive Directors and Non-Executive Directors. The Executive Directors are charged with the day-to-day management of the business connected with the Company.

The Non-Executive Directors are charged with the supervision of the performance of duties by the Executive Directors as well as the general course of affairs of the Company and the business connected with it. Each Director has a statutory duty to act in the corporate interest of the Company and its business.
As per 30 June 2022, the Board consist of:
Executive Directors: Dr. Anthony Bryan Hayward Mr. Tom James Daniel
Non-Executive Directors: Mr. Leonhard Heinrich Fischer Mr. Steve Holliday
On 6 April 2022, it was announced that Carl-Peter Forster would step down from the board of the Company effective 30 April 2022, following his appointment as Chairman of Vesuvius PLC. Mr Forster served as a non-executive director from 29 June 2021 until 30 April 2022.
100% of the Proceeds are held on an Escrow Account. During the period the escrow account was subject to Negative Interest, at European Central Bank ("ECB") variable rate minus 15 bps. Up to 50 bps of negative interest incurred per annum (up to a total of EUR 1,750,000) will be borne by the Sponsor through the Negative Interest Cover (which is part of the Costs Cover). However, there can be no assurance that the Negative Interest will not exceed the amount of the Negative Interest Cover. Neither the Company nor the Sponsor will compensate Ordinary Shareholders for any Negative Interest in excess of the Negative Interest Cover and, accordingly, the funds held in the Escrow account will be used to cover any interest in excess of the Negative Interest Cover.
The Company was admitted to listing and trading on Euronext Amsterdam on 19 July 2021 pursuant to the Private Placement in which it raised EUR 175 million in gross proceeds in accordance with the Prospectus. The Company completed the Offering of 17,500,000 Units, each consisting of one ordinary share (an "Ordinary Share") and onethird (1/3) of a warrant (a "Warrant" or "Public Warrant"), at a price of EUR 10.00 per Unit raising gross proceeds of EUR 175 million. Payment for the Ordinary Shares and the Public Warrants ("Settlement") took place on 21 July 2021 (the "Settlement Date").
The units themselves were not listed, but the shares and Warrants are listed under the respective symbols of "ENTPA" and "ENTPW". Since the listing, the Company is focused on finding a selection of potential target companies to bring to the EGM as a proposed Business Combination.
Financial highlights as per 30 June 2022:
The Company has suffered an after-tax loss of EUR 5,583,772 over the period of 1 January 2022 through 30 June 2022.

The Company has not recorded any operational revenues. The result is attributable to the operating costs and negative interest rates for large commercial deposits and to the recognition of the amortised cost impact of the redeemable Ordinary Shares and change in the fair value of the Founder Warrants and Public Warrants as derivative financial liabilities (pursuant to IAS 32) on the Company's balance sheet, which is expensed through the profit and loss and is a non-cash adjustment.
Due to the negative interest, the money held in the escrow account decreased to EUR 175,892,026 as at 30 June 2022.
Reference is made to the description of risks relating to the Company included in the Prospectus and the 2021 Annual Report, particularly risks that may be of relevance to the Company after the completion of a Business Combination and risks relating to the securities and for a cautionary note regarding forward looking statements.
Although the Company believes that the risks and uncertainties described in the Prospectus and Annual Report are the material risks and uncertainties concerning the Company's business and industry, the Units, the Ordinary Shares and the Warrants, they are not the only risks and uncertainties.
Although the risks and uncertainties as reported in the 2021 Annual Report remain applicable, financial markets are suffering from significantly increased inflation rates, interest rates and volatility. Furthermore, financing conditions have tightened. These development may have further negative effects on the financial markets, which, in turn, might have negative effects on the Euro currency and on financial institutions (including banks) in the eurozone. These developments may negatively impact the Company's ability to proceed with a Business Combination, and the potential impact of such further deterioration is high. Regarding the risk that financial institutions would be so significantly affected by the current developments that this might have a negative impact on the Company's assets, we expect a low likelihood and a high financial impact.
Other risks, events, facts or circumstances not presently known to the Company, or that the Company currently deems to be immaterial could, individually or cumulatively, prove to be important and may have a significant negative impact on the Company's business, financial condition, results of operations and prospects.
In particular, the Company has not yet identified its operational business and, therefore, the Company may face additional risks that are specific to the business or industry in which the Company will become active following the Business Combination.
Quantitative measurement of these risks is challenging and the merit of such an approach to measuring and managing them is questionable. Therefore, the Company has not implemented quantitative measures thereof, rather the judgment of the Board about these risks is the approach that the Company has chosen to take in respect of ongoing assessment and management of risks and uncertainties.
The Company's risk management objectives and policies are consistent with those disclosed in the Prospectus shown in the Governance Documents section of the Company's website (www.entpa.nl).
The Board Rules provide for a related party transaction policy in accordance with Dutch law. Related party transactions include transactions between the Company and "related parties" as defined in the related party transaction policy.
The related party transaction policy provides procedures for Directors to notify a potential related party transaction. Potential related party transactions shall be subject to review by the Board. The related party transaction policy

stipulates when a transaction qualifies as a related party transaction. No such related party transactions shall be undertaken without the approval of the Board, which approval includes the affirmative vote of the majority of the nonexecutive Directors, who are independent within the meaning of the DCGC and not considered to be conflicted with respect to the relevant related party transaction. Any Director who has a direct or indirect personal interest in the transaction, or who is considered to be conflicted with respect to the transaction, cannot participate in the discussions or decision-making with respect to the related party transaction concerned.
If the Board proposes a Business Combination to the General Meeting, and the proposed Target is a related party to the Sponsor, the Company would be entering into a related party transaction with the Sponsor. As a result, in accordance with the Company's related party transaction policy, implementation of the Business Combination would require unanimous approval of all members of the Board entitled to vote.
The Board may approve the related party transaction only if it determines that it is in the interest of the Company and the business connected with it. The Company's related party transaction policy is included in the Code of Conduct and Ethics which is available on the Company's website (www.entpa.nl).
With a view to the respective shareholdings held by the Non-Executive Directors, which in each case is below 10%, the Non-Executive Directors do qualify as 'independent' within the meaning of the Dutch Corporate Governance Code.
These condensed interim financial statements for the period ending 30 June 2022 (as well as the period ending 30 June, 2021) (the Half-Year Report and the 2021 Interim Period) (het halfjaarlijks bestuursverslag) have not been audited or reviewed by Energy Transition's statutory auditor. Consequently, all information included in this semi-annual report is unaudited.
The board of directors of Energy Transition hereby declares that to the best of its knowledge, these condensed interim financial statements, which have been prepared in accordance with IAS 34 (Interim Financial Reporting), give a true and fair view of the assets, liabilities, financial position and profit or loss of Energy Transition, and these condensed interim financial statements give a fair view of the information required pursuant to sections 5:25d(8) and 5:25d(9) of the Dutch Financial Supervision Act (Wet op het financieel toezicht).
Amsterdam, 22 September 2022
L.H. Fischer, Non-Executive Director S. Holliday, Non-Executive Director A.B. Hayward, Executive Director T.J. Daniel, Executive Director


| Note | 30 June 2022* | 31 December 2021* | 30 June 2021* | |||||
|---|---|---|---|---|---|---|---|---|
| (Unaudited) | (Audited) | (Unaudited) | ||||||
| EUR | EUR | EUR | EUR | EUR | EUR | |||
| CONTINUING | ||||||||
| OPERATIONS: | ||||||||
| Revenue | - | - | - | |||||
| Cost of sales | - | - | - | |||||
| Gross margin | - | - | - | |||||
| Other income | - | - | - | |||||
| Other expenses | (923,277) | (1,811,208) | (259,291) | |||||
| Net operating result | (923,277) | (1,81,208) | (259,291) | |||||
| Finance income | - | - | ||||||
| Finance costs | (6) | (4,660,495) | (3,326,144) | - | ||||
| Net finance costs | (4,660,495) | (3,326,144) | - | |||||
| Loss before tax | (5,583,772) | (5,137,352) | (259,291) | |||||
| Income tax | - | - | ||||||
| expense/(benefit) | ||||||||
| Loss for the period | (5,583,772) | (5,137,352) | (259,291) | |||||
| Other comprehensive income |
- | - | - | |||||
| Total comprehensive income/(loss) for |
(5,583,772) | (5,137,352) | (259,291) | |||||
| the period |
*It should be noted that the comprehensive income for the periods ended 30 June, 2022 and 30 June, 2021 relate to half year figures, whereas the 31 December 2021 figures comprise of a full year (which includes the 30 June 2021 figures).

as at 30 June 2022
(Before appropriation of result)
| Note | 30 June 2022 (Unaudited) |
31 December 2021 (Audited) |
30 June 2021 (Unaudited) |
|
|---|---|---|---|---|
| EUR | EUR | EUR | ||
| NON-CURRENT ASSETS: | ||||
| Other financial assets | (7) | 175,892,026 | 176,336,017 | - |
| Total non-current assets | 175,892,026 | 176,366,017 | - | |
| CURRENT ASSETS: | ||||
| Trade and other receivables | 208,904 | 309,469 | 149,197 | |
| Deferred IPO costs | - | - | 514,966 | |
| Prepaid expenses | 47,387 | 299,758 | 4,554 | |
| Cash and cash equivalents | (8) | 3,081,936 | 3,044,794 | 1,019,417 |
| Total current assets | 3,337,525 | 3,654,021 | 1,688,134 | |
| Total assets | 179,230,253 | 180,020,038 | 1,688,134 |
| Note | 30 June 2022 (Unaudited) |
31 December 2021 (Audited) |
30 June 2021 (Unaudited) |
|
|---|---|---|---|---|
| EUR | EUR | EUR | ||
| SHAREHOLDER'S EQUITY: | ||||
| Issued share capital | (9) | 43,550 | 43,750 | 43,750 |
| Share premium | - | - | - | |
| Accumulated loss | (5,137,352) | - | - | |
| Result for the period | (5,583,772) | (5,137,352) | (259,291) | |
| Total equity | (10,677,573) | (5,093,602) | (215,541) | |
| NON-CURRENT LIABILITIES: | ||||
| Redeemable Ordinary Shares | (5) | 169,462,229 | 166,810,547 | - |
| Founder Warrants | (5) | 11,050,000 | 10,075,000 | - |
| Public Warrants | (5) | 7,816,667 | 7,350,000 | - |
| Total non-current liabilities | 188,328,896 | 184,235,547 | - | |
| CURRENT LIABILITIES: | ||||
| Payable to Sponsor | 25,700 | 25,600 | 1,024,600 | |
| Trade and other payables | 1,553,231 | 852,493 | 879,074 | |
| Total current liabilities | 1,578,931 | 878,093 | 1,903,674 | |
| 179,230,253 | 180,020,038 | 1,688,134 |

| Attributable to owners of the Company | |||||
|---|---|---|---|---|---|
| Issued share | Share | Accumulated | Result for | Total | |
| capital | premium | loss | the period | ||
| EUR | EUR | EUR | EUR | EUR | |
| Balance as at 31 December |
43,750 | - | - | (5,137,352) | (5,093,602) |
| 2021 | |||||
| Appropriation of result | - | - | (5,137,352) | 5,137,352 | - |
| Result for the period | - | - | - | (5,583,772) | (5,583,772) |
| Other comprehensive income (loss) |
- | - | - | - | - |
| Total comprehensive income (loss) for the period |
- | - | (5,137,352) | (5,583,772) | (10,677,374) |
| Transactions with owners of the Company |
|||||
| Issuance of Founder Shares | - | - | - | - | - |
| Repurchase of Founder Shares |
(200) | - | - | - | (200) |
| Total contributions by and distributions to owners |
(200) | - | - | - | (200) |
| Balance as at 30 June 2022 |
43,550 | - | - | (5,583.772) | (10,677,573) |
| Balance as at 25 February 2021 |
- | - | - | - | - |
| Result for the period | - | - | - | (5,137,352) | (5,137,352) |
| Other comprehensive income (loss) |
- | - | - | - | - |
| Total comprehensive income | - | - | - | (5,137,352) | (5,137,352) |
| (loss) for the period | |||||
| Transactions with owners of the Company |
|||||
| Issuance of Founder Shares | 100,600 | - | - | - | 100,600 |
| Cancellation of Founder Shares | (56,850) | - | - | - | (56,850) |
| Total contributions by and | 43,750 | - | - | - | 43,750 |
| distributions to owners | |||||
| Balance as at 31 December 2021 |
43,750 | - | - | (5,137,352) | (5,093,602) |
The issued share capital of the Company consists of 4,375,000 Ordinary Shares with a par value of EUR 0.01 each (EUR 43,750). Following the resignation from Mr. Foster from the board of the Company, the Company acquired Mr. Fosters 20,000 Ordinary Shares for a consideration of EUR 200. At 30 June 2022 4,355,000 Shares were issued and fully paid.

| Note | 30 June 2022* | 31 December 2021* | 30 June 2021* | |
|---|---|---|---|---|
| (Unaudited) | (Audited) | (Unaudited) | ||
| EUR | EUR | EUR | ||
| CASH FLOW FROM OPERATING ACTIVITIES | ||||
| Loss for the period | (5,583,772) | (5,137,352) | (259,291) | |
| Adjustments for: | ||||
| -Fair value adjustments of warrants | (5)(6) | 1,441,667 | 675,000 | - |
| -Effective interest on redeemable ordinary shares | (5)(6) | 2,536,032 | 2,251,336 | - |
| -Negative interest on Escrow Account attributable to Negative Interest Cover |
(6) | 682,796 | 399,808 | - |
| -Expensed issuance costs | - | 137,940 | - | |
| Changes in: | ||||
| -Decrease / (Increase) in trade and other receivables | 100,566 | (309,469) | (664,163) | |
| -Decrease / (Increase) in prepaid expenses | 252,371 | (299,758) | (4,554) | |
| -Increase in trade and other payables | 607,682 | 721,017 | 1,903,674 | |
| Net cash flow used in operating activities | 37,342 | (1,561,478) | 975,666 | |
| CASH FLOW FROM INVESTING ACTIVITIES | ||||
| Escrow account - proceeds from issuance of Units | - | (175,000,000) | - | |
| Net cash flow from investing activities | - | (175,000,000) | - | |
| CASH FLOW FROM FINANCING ACTIVITIES | ||||
| Proceeds from issuance of Founder Shares | (9) | 69,350 | 43,750 | |
| Repurchase of Founder Shares | (9) | (200) | - | - |
| Proceeds from issuance of Founder Warrants | - | 8,751,000 | - | |
| Proceeds from interest free loan granted by Sponsor | - | 999,000 | - | |
| Proceeds from issuance of Units | - | 172,103,276 | - | |
| Transaction costs related to issuance of redeemable Ordinary Shares |
- | (566,354) | - | |
| Negative interest cover | - | (1,750,000) | - | |
| Net cash flow from financing activities | (200) | 179,606,272 | 43,750 | |
| Net increase in cash and cash equivalents | 37,142 | 3,044,794 | 1,019,416 | |
| Cash and cash equivalents as at 1 January 2022 / 25 February 2021 |
3,044,794 | - | - | |
| Effects of exchange rate changes on cash and cash equivalents |
- | - | - | |
| Cash and cash equivalents as at 30 June 2022 / 31 December 2021 / 30 June 2021 |
(7) | 3,081,936 | 3,044,794 | 1,019,416 |
*It should be noted that the statement of cashflow for the periods ended 30 June, 2022 and 30 June, 2021 relate to half year figures, whereas the 31 December 2021 figures comprise of a full year (which includes the 30 June 2021 figures).

Energy Transition Partners B.V. (the "Company") was incorporated on 25 February 2021 as a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) incorporated under Dutch law, having its official seat (statutaire zetel) in Amsterdam, the Netherlands and with its registered office at Herikerbergweg 238, Luna ArenA. 1101 CM, Amsterdam, the Netherlands and registered in the Trade Register of the Dutch Chamber of Commerce (handelsregister van de Kamer van Koophandel) under number 82018650.
The Company is a Special Purpose Acquisition Company (SPAC) with the purpose of effecting a merger, demerger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination with, or acquisition of, a business or company (a "Target") (a "Business Combination") operating in the energy transition sector that is headquartered or operating in Europe (including UK), although it may pursue a business combination opportunity in any geography, industry or sector. Energy Transition Sponsor LLP (the "Sponsor") is the Sponsor of the Company.
The issued share capital of the Company consists of 4,355,000 shares (31 December 2021: 4,375,000 shares) with a par value of EUR 0.01 each (EUR 43,550 (31 December 2021: EUR 43,750)). The issued shares are held by the Sponsor, Non-Executive Directors and Cornerstone Investors.
The Company was admitted to listing and trading on Euronext Amsterdam (the "Admission"), the regulated market operated by Euronext Amsterdam N.V. ("Euronext Amsterdam") on 19 July 2021 pursuant to a private placement (the "Private Placement" or "Offering") in which it raised EUR 175 million in gross proceeds (the "Proceeds") in accordance with the terms and conditions set out in the Company's prospectus which has been issued on 15 July 2021 (the "Prospectus"). The Company completed the Offering of 17,500,000 units (the "Units"), each consisting of one ordinary share (an "Ordinary Share") and one-third (1/3) of a warrant (a "Warrant" or "Public Warrant"), at a price of EUR 10.00 per Unit raising gross proceeds of EUR 175 million. Payment for the Ordinary Shares and the Public Warrants ("Settlement") took place on 21 July 2021 (the "Settlement Date").
During the period under review the Company did not employ any personnel and, consequently, no payments for wages, salaries or social securities were made.
The Company's business strategy is to identify, combine with and maximise the value of a Target with operations in the Target Sector. In executing this strategy, the Company will look for a Target that (i) complements the experience of the Founders, (ii) can benefit from the Founders' operating and financial expertise and (iii) represents a compelling investment opportunity for the Company and its investors. The Company will focus its efforts on opportunities where the Company feels it has a competitive advantage and is best situated to enhance the value of the Company through a Business Combination. The ultimate goal of Business Strategy is to maximize value for investors, which, given its focus on the Target Sector, the Company believe it can do while at the same time offering solutions to the climate change and other environmental issues that the world faces today.
The Founders have an extensive network of contacts that they intend to leverage in their efforts to identify an attractive Target. Additionally, the Founders have worked together for over a decade. The Company believes this existing network and long history of working together are advantages in sourcing potential Targets and effectively running the Company. The Company also believes that its Founders' reputation, experience and track record will make it a preferred partner for potential Targets.

In addition, the Company believes that the breadth of the Founders' experience is a competitive advantage. The Founders have experience across the Target Sector and have invested across the capital structure in both private and publicly traded companies. As a result, the Founders believe they have a strong understanding of key macroeconomic trends, investor expectations and market sentiment driving the Energy Transition.
Following the Offering and prior to the Business Combination Date, the Company will not engage in any operations, other than in connection with the selection, structuring and completion of the Business Combination.
Once a concrete Target has been identified, the Company will enter into negotiations with the Target's current owners including, if appropriate, for the purpose of agreeing transaction documentation appropriate for the potential Business Combination.
The Company believes that conducting comprehensive due diligence on prospective investments is important within the Target Sector. In evaluating a prospective Target, the Company expects to conduct a due diligence review which is likely to encompass, among other things, meetings with incumbent management, investors and employees, document reviews, inspection of facilities, as well as a review of scientific, regulatory, operational, financial, legal and other information made available to the Company.
Once the transaction documentation is agreed, the Company will convene an extraordinary shareholder meeting and propose the Business Combination to the Shareholders (the "Business Combination EGM"). The approval of the Business Combination will require a simple majority (over 50% of the votes cast on the Shares) approval of the General Meeting without any quorum requirement. Depending on the nature of the transaction, other resolutions may also need to be passed which could have a higher voting threshold and/or have a quorum requirement. The Company aims to complete the Business Combination using cash from the net proceeds of the Offering, the Founder Private Placement and the settlement of the Sponsor Loan, the proceeds of the sale or issuance of Shares in connection with its Business Combination, Shares issued to the owners of the Target, debt issued to banks or other lenders or the owners of the Target, or a combination of the foregoing.
The Company may also seek to raise additional funds through a private offering of equity securities, or securities convertible into, exchangeable or exercisable for equity securities in connection with the completion of its Business Combination, and the Company may effectuate its Business Combination using the proceeds of such offering in addition to using the amounts held in the Escrow Account.
If no Business Combination is completed by the Business Combination Deadline, the Company intends to, as soon as reasonably possible, initiate the Redemption Arrangement and will also as soon as possible, and in any event within no more than two months from the Business Combination Deadline, convene a General Meeting for the purpose of adopting a resolution to dissolve and liquidate the Company. The Sponsor has committed in the Letter Agreement, and the independent, non-executive Directors have committed in their Appointment Letters, to vote all Shares (other than the Founder Share F1) held by them in favour of a Liquidation. As a result of a Liquidation, the assets of the Company will be liquidated, including the outstanding amounts deposited in the Escrow Account and substantially all of the liquidation surplus, after satisfaction of creditors (including taxes) and payment of liquidation costs, if any, will be distributed in accordance with the Liquidation waterfall. Any contingent liabilities will delay completion of the Liquidation until such time that they become actual.
If the Company completes the Business Combination, it is intended that Shareholders will remain shareholders in a listed and publicly traded company. The Shareholders will be either: (i) direct shareholders of an entity that consolidates the Company and the Target whereby the former shareholders of the Target are expected to hold an interest; or (ii) direct shareholders of the Company whereby the Company will hold all shares in the Target.

As a result of the foregoing, Shareholders, together with the Sponsor, may jointly hold a stake of between 20% and 100% in the Target, although smaller stakes cannot be excluded for a larger Target. In any event, it is intended that the shares held by Ordinary Shareholders following the Business Combination will continue to be listed and publicly traded and the Ordinary Shareholders will retain the right to vote and the right to receive dividends and other distributions declared by the Company (or any successor or surviving entity following the Business Combination). Furthermore, the Shareholders and the Company are expected to remain subject to all regulations applicable to them as a consequence of a public listing on Euronext Amsterdam.
Subject to an arrangement and timetable to be negotiated with the shareholders of the Target, the Company may consider fully merging the Company and the Target, as part of which the Target is envisaged to be fully absorbed into the Company. The merger of the Company and the Target may occur immediately in the context of the Business Combination or at a later stage. The shareholders' circular published for the Business Combination EGM will contain the details of such merger and the then envisaged timetable for it.
After the merger, the Company will continue to exist, provided that it will assume the name of the Target and that the Company will become a holding company that carries out a commercial business strategy.
At such point in time, it is intended that the Target, through the Company as a holding company, will be admitted to listing and trading. The Company may also simultaneously pursue a Business Combination with several Targets resulting in a single operating business, and references to Target should be taken as to include such a situation.
These condensed interim financial statements have been prepared in accordance with the IAS 34 Interim Financial Reporting standards. Although these condensed interim financial statements do not contain all information required under IFRS, they do give a true and fair view of the assets and liabilities, the financial position and the profit or loss, the management report provides a true and fair view and the significant risks and uncertainties to which the Company is exposed have been described. These condensed interim financial statements should be read in conjunction with the Prospectus and the 2021 Annual Report.
The condensed interim financial statements of the Company have been prepared on the basis of the going concern assumption.
The Company will have until 24 months from 21 July 2021 (''Settlement Date''), plus an additional six months subject to approval by the General Meeting (''Business Combination Deadline'') to complete the Business Combination. If no Business Combination is completed by the Business Combination Deadline, the Company intends to, as soon as reasonably possible, and in any event, within no more than two months from the Business Combination Deadline, at the proposal of the Board convene a General Meeting for the purpose of adopting a resolution to:

The holder of the Founder Share F1 and holders of Warrants and Founder Warrants will not receive any distribution in a Liquidation and all such Warrants and Founder Warrants will automatically expire without value upon the failure by the Company to complete a Business Combination by the Business Combination Deadline.
These conditions indicate the existence of a material uncertainty, which may cast significant doubt about the Company's ability to continue as a going concern. Since the Settlement Date, the Company has been focusing on the selection of a potential target company for the initial Business Combination and the process is currently ongoing.
The (financial) risk for our shareholders is largely mitigated by the fact that the Company holds EUR 175,892,026 (less negative interest) in the Escrow Accounts as at 30 June 2022, which can be released upon meeting strict requirements.
Furthermore, the Company has EUR 3,081,936 of cash available in the current account as at 30 June 2022, coming from the proceeds of the sale of the Founder Shares and Warrants at the Offering (Capital at Risk), which is considered to be sufficient to cover working capital and other running costs and expenses.
If no Business Combination is completed, the exposure of the Ordinary Shareholders is generally limited to the negative interest incurred by the Company over the amounts held in the Escrow Accounts which exceed the Negative Interest Cover (see note 6 "Other financial assets").
As there is reasonable expectation that the Company will be able to continue its operations and meet its liabilities for at least twelve months, therefore, it is appropriate to adopt the going concern basis in preparing the financial reporting.
These condensed interim financial statements have been prepared on the historical cost basis, except financial instruments that are measured at revalued amounts or fair values at the end of each reporting period, as explained in the accounting policies below.
The condensed interim financial statements are presented in Euro, which is the Company's functional currency. Functional currency is the currency of the primary economic environment in which the entity operates. The issued share capital of the Company is denominated in Euro. The Directors of the Company believe that Euro most faithfully represents the economic effects of the underlying transactions, events and conditions.
Except as otherwise indicated, all financial information is presented in EUR.

The preparation of the condensed interim financial statements in conformity with IFRSs requires management to make judgments, estimates and assumptions that may affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.
The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.
Significant areas of estimation, uncertainty and critical judgements in applying accounting policies that have the most significant effect on the amounts recognised in the condensed interim financial statements relate to the Founder Shares, Founder Share F1 and Founder Warrants, Redeemable Ordinary Shares, Escrow Account and transaction costs.
Reference is made to the Prospectus and 2021 Annual Report for further details on these accounting judgements and estimates.
The Company is exposed to a variety of financial risks: credit risk, interest rate risk and liquidity risk. The Company's overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Company's financial performance. Reference is made to the Prospectus and 2021 Annual Report for further details on these risks.
The Company's objectives when managing capital is to safeguard the Company's ability to continue as a going concern and maintain an optimal capital structure to reduce the cost of capital. The Company is not subject to any externally imposed capital requirements.
The Company manages its capital to ensure the Company will be able to continue as going concern while maximizing the return to stakeholders through the optimization of the debt and equity balance. The capital structure of the Company consists of debt and equity of the Company. The Company is not subject to any externally imposed capital requirements. The Company's Board reviews the capital structure of the Company.
The Company measures fair values using the following fair value hierarchy that reflects the significance of the inputs used in making the measurements.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or, in its absence, the most advantageous market to which the Company has access at that date. The fair value of a liability reflects its non-performance risk.
The determination of what constitutes "observable" requires significant judgment by management. Fair values of financial assets and liabilities that are traded in active markets are based on quoted market prices or dealer price quotations. A market is regarded as "active" if transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an on-going basis.
The determination of fair value for financial assets and liabilities for which there is no observable market price requires the use of valuation techniques. For financial instruments that trade infrequently and have little price transparency, fair value is less objective, and requires varying degrees of judgment depending on liquidity, concentration, uncertainty of market factors, pricing assumptions and other risks affecting the specific instrument.
Level three valuations are mainly based on using valuation techniques. Valuation techniques include net present value techniques, the discounted cash flow method, comparison to similar instruments for which market observable prices exist, and valuation models.
Fair value estimates are made at a specific point in time, based on market conditions and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgments e.g. interest rate, volatility, credit spreads, probability of defaults, estimated cash flows etc. and therefore, cannot be determined with precision.
The Company recognises transfers between levels of the fair value hierarchy as at the end of the reporting period during which the change has occurred. There were no transfers between Level 1, 2 and 3 during the reporting period.
The Company initially recognises all financial assets and liabilities at fair value on the trade date at which the Company becomes a party to the contractual provisions of the instruments.
Any gains and losses arising from changes in fair value of the financial assets or financial liabilities at fair value through profit or loss are recorded in the statement of comprehensive income.
Financial assets and financial liabilities are measured initially at fair value plus or minus, for an item not at fair value through profit or loss ("FVTPL"), transaction costs that are directly attributable to its acquisition or issue.
On initial recognition, the Company classifies financial assets as measured at amortised cost or FVTPL.
A financial asset is measured at amortised cost if it meets both of the following conditions and is not designated as at FVTPL:

All financial assets not classified as measured at amortised cost as described above are measured at FVTPL.
Financial assets measured at amortised cost are subsequently measured at amortised cost using the effective interest method. The amortised cost is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognised in profit or loss. Any gain or loss on derecognition is recognised in profit or loss.
Financial assets measured at FVTPL are subsequently measured at fair value. Net gains and losses, including any interest income and foreign exchange gains and losses, are recognised in profit or loss.
Financial liabilities are classified as measured at amortised cost or FVTPL.
A financial liability is classified as at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains or losses, including any interest, are recognised in profit or loss.
Other financial liabilities are subsequently measured at amortised cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognised in profit or loss. Any gain or loss on derecognition is also recognised in profit or loss.
The amortised cost of a financial asset or financial liability is the amount at which the financial asset or financial liability is measured on initial recognition minus the principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount and, for financial assets, adjusted for any loss allowance.
The Company assesses on a forward-looking basis the expected credit losses associated with its financial assets carried at amortised cost. The Company recognises a loss allowance for such losses at each reporting date.
The measurement of expected credit losses reflects:
The Company derecognises a financial asset when the contractual rights to the cash flows from the asset expire, or it transfers the rights to receive the contractual cash flows on the financial asset in a transaction in which substantially all the risks and rewards of ownership of the financial asset are transferred or in which the Company neither transfers nor retains substantially all of the risks and rewards of the ownership and does not retain control of the financial asset.
The Company derecognises a financial liability when its contractual obligations are discharged or cancelled or expired. On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is profit or loss.

Financial assets and liabilities are offset, and the net amount presented in the statement of financial position when, and only when, the Company has a legal right to offset the amounts and intends either to settle on a net basis or to realise the asset and settle the liability simultaneously. Income and expenses are presented on a net basis only when permitted by the accounting standards.
The Company has assessed the instruments issued by the Company whether they should be accounted for as sharebased payments within the scope of IFRS 2 or as financial instruments within the scope of IAS 32 Financial instruments. This assessment involves consideration of all terms and conditions attached to the instruments and as to whether the instruments were issued by the Company for a service to the Company, potentially at a discount or subject to service or performance conditions. The Board concluded that Ordinary Shares, Founder Shares as well as Market Warrants and Founder Warrants should be accounted for under IAS 32.
The Founder Shares are ordinary shares in the capital of the Company. The Sponsor, Cornerstone investors and non-executive Directors have committed to certain lock-up procedures and waived in the letter agreement their rights to dividends and other distributions declared and paid on the Founder Shares until completion of a Business Combination. Subject to the satisfaction of the conditions set out below:
The Founder Shares are not covered under the Share Repurchase Arrangement. There is no contractual obligation for the Company to repay the holders of the Founder Shares. While the Company may pay dividends to Sponsor Shareholders and not to founder shareholders while they are required to waive their right to dividends, the dividend rights of the founder shares are the same as those of the Ordinary Shares and the granting of dividends is at the discretion of the Company. Thus, the Company is not contractually obligated to make any payment. Hence, the Founder shares are classified as equity instruments per IAS 32.
At initial recognition, the Founder Shares are recognized at fair value less transaction costs (IAS 32.35). No subsequent changes to initial recognition are recognized (IAS 32.36).
The Company is accounting for the Ordinary Shares in accordance with the guidance contained in IAS 32 Financial Instruments: Presentation. IAS 32 provides that the Company's financial instruments shall be classified on initial recognition in accordance with the substance of the contractual arrangement and the definitions of a financial liability or an equity instrument.
The Company classifies the Ordinary Shares as financial liabilities due to its redeemable feature. IFRS 9 Financial Instruments provides that at initial recognition, financial liabilities are measured at fair value.

After initial recognition, financial liabilities that are not derivatives are subsequently measured at amortised cost. Accordingly, the Company will initially recognise each Ordinary Share as a liability at its fair value and subsequently measure each Ordinary Share at amortised cost. The Ordinary Shares are also subject to derecognition when, and only when, the financial liability is extinguished – i.e. when the obligation specified in the contract is discharged or cancelled or expires.
| 30/06/2022 | 30/06/2022 | ||
|---|---|---|---|
| EUR | Units | EUR | |
| Proceeds from issuance of units | 172,103,276 | ||
| Deducted issuance costs** | 2,896,724 | ||
| Gross proceeds from issued Units | 17,500,000 | 175,000,000 | |
| Ordinary Shares | 175,000 | ||
| Ordinary Share Premium Reserve | 174,825,000 | ||
| Less: initial recognition of Public Warrants | 5,833,333 | (7,000,000) | |
| Less: underwriter fees | (2,758,784) | ||
| Less: other transaction costs related to issuance of | (566,354) | ||
| Ordinary Shares | |||
| Carrying amount as at 21 July 2021 (Offering) | 164,674,862 | ||
| Other changes | |||
| -Effective interest on redeemable ordinary shares | 2,251,336 | ||
| -Pro-rata share of negative interest in excess of | (115,651) | ||
| Negative Interest Cover | |||
| Carrying amount as at 31 December 2021 | 166,810,547 | ||
| -Effective interest on redeemable ordinary shares | 2,536,032 | ||
| -Pro-rata share of negative interest in excess of | 115,651 | ||
| Negative Interest Cover (reversal) | |||
| Carrying amount as at 30 June 2022 | 169,462,229 |
**including EUR 137,940 issuance costs which has been expensed.
The fair value of redeemable Ordinary Shares was EUR 172.4 million based on the closest trading price as at 30 June, 2022 (EUR 170.6 million as at 31 December 2021).
The Company is accounting for the Public Warrants and the Founder Warrants in accordance with IAS 32 Financial Instruments: Presentation. IAS 32 provides that the Company's financial instruments shall be classified on initial recognition in accordance with the substance of the contractual arrangement and the definitions of a financial liability or an equity instrument.
Founder Warrants have substantially the same terms as the Public Warrants, except that they are not admitted to listing and trading on any trading platform, cannot be redeemed without the holder's consent, and can be exercised on a cashless basis by the Sponsors and their Permitted Transferees.
Each whole Public Warrant entitles an eligible holder to subscribe for one Ordinary Share against payment of the exercise price. There is an additional settlement option under which the Public Warrants can be called by the SPAC in case the share price reaches a certain level. This redemption includes either a cash redemption or exercising the Public Warrant on a cashless basis.

As a result of these cashless exercise features, the Company will classify the Public Warrants and the Founder Warrants as derivative financial liabilities. IFRS 9 Financial Instruments provides that at initial recognition, financial liabilities are measured at fair value. After initial recognition, financial liabilities that are derivatives are subsequently measured at fair value. The Warrants and Founder Warrants are subject to re-measurement at each balance sheet date.
With each such re-measurement, the Public Warrant and Founder Warrant liability will be adjusted to fair value, with the change in fair value recognised in the Company's profit or loss in the statement of comprehensive income.
The Warrants and Founder Warrants are also subject to derecognition when, and only when, the financial liability is extinguished, i.e. when the obligation specified in the contract is discharged or cancelled or expires.
The Founder Warrants were initially recorded at the transaction price of EUR 1.50 which is deemed to be the fair value.
Since the Founder Warrants are not publicly traded and there are no comparable quoted financial instruments, alternative valuation techniques were used to determine their fair value at inception and at year end. Using a binomial option pricing model whilst applying a volatility of 40% and adjusting for a 50% probability of a successful Business Combination, at 30 June 2022 / 31 December 2021 the fair value of the Founder Warrants was estimated to be EUR 1.70 / EUR 1.55.
As the lowest level significant input in this valuation is unobservable (i.e. the volatility and success probability), this is a Level 3 valuation. The sensitivity of the valuation to changes in the two unobservable inputs are:
| Input / 30 June 2022 |
Sensitivity | Founder Warrant value | |
|---|---|---|---|
| Volatility estimate (40%) | +/-10% | +€0.44/-€0.46 | +26%/-27% |
| Success probability (50%) | +/-10% | +€0.34/-€0.34 | +20%/-20% |
The Public Warrants were initially recorded at a fair value determined by using a binomial option pricing model whilst applying a volatility of 40% and adjusting for a 50% probability of a successful Business Combination. At the Offering, the fair value of the Public Warrants was estimated to be EUR 1.20.
Although the Public Warrants are traded in a public market, there was very limited trading activity around the balance sheet date, therefore Management had determined the fair value of the Public Warrants using a similar binomial option pricing model with consistent assumptions as the Founder Warrants. The fair value of the Public Warrants at 30 June 2022 / 31 December 2021 was estimated to be EUR 1.34 / EUR 1.26.
As the lowest level significant input in this valuation is unobservable (i.e. the volatility and success probability), this is a Level 3 valuation. The sensitivity of the valuation to changes in the two unobservable inputs are:

| Input / 30 June 2022 |
Sensitivity | Public Warrant value | |
|---|---|---|---|
| Volatility estimate (40%) | +/-10% | +€0.24/-€0.33 | +18%/-25% |
| Success probability (50%) | +/-10% | +€0.27/-€0.27 | +20%/-20% |
The same binomial option pricing model is used to determine the fair value of both, the Founder Warrants and the Public Warrants, as at 30 June 2022 and 31 December 2021 and the fair values are disclosed in the tables below:
| 30 June 2022 |
Number | Initial value | Fair value at | Total value as |
|---|---|---|---|---|
| 30/06/22 | per 30/06/22 | |||
| EUR | EUR | EUR | ||
| Founder Warrants | 6,500,000 | 1.5 | 1.70 | 11,050,000 |
| Sponsor | 5,525,000 | |||
| Cornerstone investors | 975,000 | |||
| Public Warrants | 5,833,333 | 1.2 | 1.34 | 7,816,666 |
The following table presents the changes in Level 3 fair value items for the period ended 30 June 2022:
| Public | Founder | Total | |
|---|---|---|---|
| Warrants | Warrants | ||
| EUR | EUR | EUR | |
| Opening balance as at 25 February 2021 | - | - | - |
| -Issuance of instruments | 7,000,000 | 9,750,000 | 16,750,000 |
| -(Gains)/losses recognised in statement of profit or | 350,000 | 325,000 | 675,000 |
| loss | |||
| Closing balance as at 31 December 2021 | 7,350,000 | 10,075,000 | 17,425,000 |
| -(Gains)/losses recognised in statement of profit or | 466,666 | 975,000 | 1,441,666 |
| loss | |||
| Closing balance as at 30 June 2022 | 7,816,666 | 11,050,000 | 18,866,666 |
All losses in the table above are unrealized and relate to the Market Warrants and Founder Warrants held at the balance sheet date. Gain/losses are recorded in the line item "Fair value adjustment of warrants" in the statement of profit or loss and other comprehensive income.
Prepaid expenses relate to amounts paid in advance. They are subsequently measured at amortised cost using the straight line method.
Trade and other receivables relate to an amount due from tax authority for Value Added Tax. As collection is expected in one year or less, they are classified as current assets.
Trade and other receivables are recognised initially at their transaction price, the amount of consideration that is unconditional, unless they contain significant financing components when they are recognised at fair value. They are subsequently measured at amortised cost using the effective interest method, less loss allowance.

Cash comprises of current account. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash, have original maturities of three months or less, are subject to an insignificant risk of changes in value and are held for purpose of meeting short-term cash commitments rather than for investments or other purposes.
Cash and cash equivalents are carried at nominal value in the statement of financial position.
Share capital represents the nominal value of the shares issued by the Company. To the extent such shares remain unpaid as of the end of the reporting period a corresponding receivable is presented in other assets.
Share premium decreases and other capital distributions are recognised as a liability provided they are declared before the end of the reporting period. Capital distributions declared after the end of the reporting period are not recognised as a liability but are disclosed in the notes.
Trade and other payables represent liabilities for services provided to the Company prior to the end of the financial period, which are unpaid. Trade and other payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are recognised initially at their fair value. Whereby the best evidence of the fair value of a financial instrument at initial recognition is normally the transaction price (i.e. the fair value of the consideration received). Subsequent measurement is at amortised cost using the effective interest method.
Other expenses are expenditures incurred for the running and administration of the Company.Expenses are attributed to the reporting period to which they pertain.
Finance expenses include interest on the Company's cash and cash equivalent balances, negative interest payable on cash held in the Escrow account (limited to the Negative Interest Cover), fair value changes and amortised cost adjustments of the redeemable Ordinary Shares.
Assets and liabilities, denominated in foreign currencies are translated into the functional currency at exchange rates prevailing on the reporting date. Transactions in foreign currencies are translated into Euro at the exchange rate at the dates of the transactions.
Foreign exchange gains and losses arising from translation, if any, are included in the statement of comprehensive income.
The Company is subject to corporate income tax and it is considered VAT entrepreneur for the Dutch Tax Authorities.
Income tax expense comprises current and deferred tax. Income tax expense is recognised in the income statement except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.

Current tax is the expected tax payable on the taxable income for the year, using the tax rates applicable to the Company's activities enacted or substantially enacted at the statement of financial position date, and any adjustments to tax payable in respect of the previous year.
Deferred taxes are calculated on the latent gain or loss on the instruments recognised at the fair value, by applying tax rate applicable to the regime of each instrument. Deferred tax assets and liabilities are not discounted.
The Company's tax jurisdiction is the Netherlands.
The cash flow statement is prepared in accordance with the indirect method, whereby profit or loss is adjusted for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments, and items of income or expense associated with investing or financing cash flows. Non-cash transactions are not included in the statement of cash flows. The Company has chosen to present interest paid on cash and cash equivalents as operating cash flows.
The liquidities in the cash flow statements comprise of cash in hand, current balances with banks and call deposits with maturities of less than 3 months. Cash flows in foreign currencies are translated at estimated average rates.
All legal entities that can be controlled, jointly controlled or significantly influenced are considered to be a related party. Also, entities which can control the Company are considered a related party. In addition, statutory directors and close relatives are regarded as related parties.
Significant transactions with related parties are disclosed in note 19 "Related party transactions".
The activities of the Company are considered to be a single operating segment under IFRS 8. Hence no further segmental disclosures are included in the condensed interim financial statements.

Finance costs are comprised as follows:
| 01/01/22- | 25/02/21- | |
|---|---|---|
| 30/06/22 | 31/12/21 | |
| EUR | EUR | |
| Effective Interest on redeemable ordinary shares | 2,536,032 | 2,251,336 |
| Fair value changes financial derivative liabilities | 1,441,667 | 675,000 |
| Negative interest on Escrow Account attributable to Negative Interest Cover | 682,795 | 399,808 |
| 4,660,495 | 3,326,144 |
| 30/06/22 | 31/12/21 | |
|---|---|---|
| EUR | EUR | |
| Escrow account | 175,892,026 | 176,366,017 |
The escrow account is held with J.P. Morgan AG.
On 21 July 2021, deposit was made to the escrow account which comprises of:
100% of the Proceeds are held on an Escrow Account. During the period the escrow account was subject to Negative Interest, initially at European Central Bank ("ECB") variable rate minus 15 bps. Up to 50 bps of negative interest incurred per annum (amounting to up to EUR 1,750,000) will be borne by the Sponsor through the Negative Interest Cover (which is part of the Costs Cover). However, there can be no assurance that the Negative Interest will not exceed the amount of the Negative Interest Cover. Neither the Company nor the Sponsor will compensate Ordinary Shareholders for any Negative Interest in excess of the Negative Interest Cover and, accordingly, the funds held in the Escrow account will be used to cover any interest in excess of the Negative Interest Cover.
| 30/06/22 | 31/12/21 | |
|---|---|---|
| EUR | EUR | |
| Unrestricted cash at bank | 3,081,936 | 3,044,794 |
The unrestricted cash at bank is held with J.P. Morgan AG and is at free disposal of the Company.

Share capital
| Notes | 30/06/22 | 31/12/21 | 30/06/22 | 31/12/21 | |
|---|---|---|---|---|---|
| Shares | Shares | EUR | EUR | ||
| Ordinary shares | |||||
| Paid | 4,355,000 | 4,375,000 | 43,550 | 43,750 | |
| Unpaid | 20,000 | - | - | - | |
| 4,375,000 | - | 43,550 | 43,750 | ||
| Total share capital | i | 4,375,000 | - | 43,550 | 43,750 |
| Notes | Number | |
|---|---|---|
| of shares | ||
| Opening balance as at 25 February 2021 | - | |
| Issuance of ordinary shares | 6,250,000 | |
| Issuance of ordinary shares | 3,750,000 | |
| Reduction of nominal value | - | |
| Increase of nominal value | - | |
| Share cancellation | (3,125,000) | |
| Share cancellation | (60,000) | |
| Issuance of ordinary shares | 60,000 | |
| Share cancellation | (2,500,000) | |
| Closing balance as at 31 December 2021 | 4,375,000 | |
| Repurchase shares | ii | (20,000) |
| Closing balance as at 30 June 2022 | 4,355,000 |
Reference is made to the Prospectus and 2021 Annual Report for further details regarding the movements for the period from 25 February 2021 to December 31, 2021.
ii On 6 April 2022, it was announced that Carl-Peter Forster would step down from the board of the Company effective 30 April 2022, following his appointment as Chairman of Vesuvius PLC. Mr Forster served as a non-executive director from the 29 June 2021 until 30 April 2022. In connection with Mr Forster's resignation from the Board, Mr Forster and the Company have entered into an agreement for the acquisition by the Company of all of the 20,000 Ordinary Shares in the Company's capital held by Mr Forster, against an aggregate purchase price of EUR 200.
Under Dutch law, the Company is not required to have, and does not have, an authorised share capital (maatschappelijk kapitaal), because it is a private company with limited liability.

Apart from directors, the Company has no employees and currently has no intension to hire any employees prior to a Business Combination.
All legal entities that can be controlled, jointly controlled or significantly influenced are considered to be a related party. Also, entities which can control the Company are considered a related party. In addition, statutory directors and close relatives are regarded as related parties.
Other than the issuance of the Founder Shares and Founder Warrants to the Sponsor and the Non-Executive Directors, and the remuneration between the Company and the Directors, there have been no related party transactions.
| 30 June 2022 | Number of | Issued/ | Transferred | Transferred | Number of |
|---|---|---|---|---|---|
| shares, beginning of |
Repurchased | to Non Executive |
to Cornerstone |
shares, end of period |
|
| period | directors | investors | |||
| Sponsor Shares | |||||
| Energy Transition Sponsor LLP | 3,658,750 | - | - | - | 3,658,750 |
| Non-Executive directors' shares | |||||
| Carl Peter Edmund Moritz Forster | 20,000 | (20,000) | - | - | - |
| Leonhard Heinrich Fischer | 20,000 | - | - | - | 20,000 |
| Steve Holliday | 20,000 | - | - | - | 20,000 |
| 30 June 2022 | Number of shares, beginning of period |
Issued / Repurchased |
Transferred to Non Executive directors |
Transferred to Cornerstone investors |
Number of shares, end of period |
|---|---|---|---|---|---|
| Sponsor Warrants | |||||
| Energy Transition Sponsor LLP | 5,525,000 | - | - | 5,525,000 |
Remuneration of managing directors
The board structure consists of two Executive Directors and two Non-Executive Directors.
Each Executive Director serves for a remuneration of EUR 50,000 gross per annum. Each Non-Executive Directors serves for a remuneration of EUR 25,000 gross per annum.
These remunerations have been recorded under other expenses.

The Company is focusing on the selection of a potential target partnership (a "Business Combination") with a business or company operating in the energy transition sector. The successful Business Combination will give rise to expenses of up to approximately EUR 6,371,587 (including VAT). These expenses are payable upon a successful Business Combination. Majority of these expenses relate to the costs payable to the underwriters, estimated to be up to EUR 5.8 million deferred commission and discretionary deferred commission. These expenses will be payable by the post Business Combination entity and born by all post Business Combination shareholders.
On 27 July 2022 the negative ECB deposit rate of -0.5% was increased to 0.0%. This reduced the monthly negative interest expense on the Escrow Account from that date. Subsequently, on 8 September 2022, the ECB deposit rate was raised by an additional 0.75%. Thereafter, the monthly interest on the Escrow Account will be positive.
We are not aware of any further subsequent events that need to be disclosed.
The condensed interim financial statements were authorised for issue by the Board of Directors on 22 September, 2022.
Amsterdam, 22 September 2022
L.H. Fischer S. Holliday Non-Executive Director Non-Executive Director
A.B. Hayward T.J. Daniel
Executive Director Executive Director
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.